acquired
Stage
2
Investors
About
Clinical-stage biopharmaceutical company developing proprietary immunotherapy technology to harness the immune system to combat cancer.
Explore checkmate pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.